Intestinal depletion of NaPi-IIb/Slc34a2 in mice: Renal and hormonal adaptation

Journal of Bone and Mineral Research

Volumn 30, Issue 10, 2015, Pages 1925-1937

  Hernando, Nati ^a   Myakala, Komuraiah ^a   Simona, Fabia ^a   Knöpfel, Thomas ^a   Thomas, Linto ^a   Murer, Heini ^a   Wagner, Carsten A ^a   Biber, Jürg ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

FGF 23; phosphate homeostasis; PTH; SLC34A1; vitamin D3

Indexed keywords

CALCITRIOL; CALCIUM ION; CREATININE; DENTIN MATRIX PROTEIN 1; FIBROBLAST GROWTH FACTOR 23; PHOSPHATE; PROCOLLAGEN C PROTEINASE; SODIUM PHOSPHATE COTRANSPORTER 2B; FIBROBLAST GROWTH FACTOR; MESSENGER RNA; SLC34A2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUSH BORDER; CONTROLLED STUDY; FEMALE; GENOTYPE; HOMOZYGOTE; ILEUM; MALE; MOUSE; NONHUMAN; PHOSPHATURIA; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN EXPRESSION; URINARY EXCRETION; VITAMIN BLOOD LEVEL; WILD TYPE; ACTIVE TRANSPORT; ANIMAL; BLOOD; FAMILIAL HYPOPHOSPHATEMIC RICKETS; GENETICS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; MICROVILLUS; PATHOLOGY; URINE;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; FEMALE; FIBROBLAST GROWTH FACTORS; HYPOPHOSPHATEMIA, FAMILIAL; ILEUM; KIDNEY; MALE; MICE; MICE, KNOCKOUT; MICROVILLI; PHOSPHATES; RNA, MESSENGER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB;

EID: 84942195072     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2523     Document Type: Article

References (53)

1. Bergwitz C, Jüppner H., Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med. 2010; 61: 91-104.
2. Hu MC, Shiizaki K, Kuro-o M, Moe OW., Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol. 2013; 75: 503-33.
3. Alizadeh Naderi AS, Reilly RF,. Hereditary disorders of renal phosphate wasting. Nat Rev Nephrol. 2010 Nov; 6 (11): 657-65.
4. Paloian NJ, Giachelli CM., A current understanding of vascular calcification in CKD. Am J Physiol Renal Physiol. 2014 Oct 15; 307 (8): F891-900.
5. Biber J, Hernando N, Forster I,. Phosphate transporters and their function. Annu Rev Physiol. 2013; 75: 535-50.
6. Forster IC, Hernando N, Biber J, Murer H., Phosphate transporters of the SLC20 and SLC34 families. Mol Aspects Med. 2013; 34 (2-3): 386-95.
7. Wagner CA, Hernando N, Forster IC, Biber J,. The SLC34 family of sodium-dependent phosphate transporters. Pflugers Archiv. 2014; 466 (1): 139-53.
8. Giral H, Caldas Y, Sutherland E, et al., Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol. 2009; 297 (5): F1466-75.
9. Xu H, Bai L, Collins JF, Ghishan FK., Molecular cloning, functional characterization, tissue distribution, and chromosomal localization of a human, small intestinal sodium-phosphate (Na+-Pi) transporter (SLC34A2). Genomics. 1999; 62 (2): 281-4.
10. Radanovic T, Wagner CA, Murer H, Biber J., Regulation of intestinal phosphate transport. I. Segmental expression and adaptation to low-P(i) diet of the type IIb Na(+)-P(i) cotransporter in mouse small intestine. Am J Physiol Gastrointest Liver Physiol. 2005; 288 (3): G496-500.
11. Hilfiker H, Hattenhauer O, Traebert M, Forster I, Murer H, Biber J,. Characterization of a murine type II sodium-phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci U S A. 1998; 95 (24): 14564-9.
12. Corut A, Senyigit A, Ugur SA, et al., Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet. 2006; 79 (4): 650-6.
13. Chen DR, Chien SY, Kuo SJ, et al., SLC34A2 as a novel marker for diagnosis and targeted therapy of breast cancer. Anticancer Res. 2010; 30 (10): 4135-40.
14. Shyian M, Gryshkova V, Kostianets O, et al., Quantitative analysis of SLC34A2 expression in different types of ovarian tumors. Exp Oncol. 2011; 33 (2): 94-8.
15. Sabbagh Y, O'Brien SP, Song W, et al., Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol. 2009; 20 (11): 2348-58.
16. Lee GJ, Marks J,. Intestinal phosphate transport: a therapeutic target in chronic kidney disease and beyond? Pediatr Nephrol. 2015 Mar; 30 (3): 363-71.
17. Marks J, Debnam ES, Unwin RJ,. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol. 2010; 299 (2): F285-296.
18. Hattenhauer O, Traebert M, Murer H, Biber J,. Regulation of small intestinal Na-P(i) type IIb cotransporter by dietary phosphate intake. Am J Physiol. 1999; 277 (4 Pt 1): G756-762.
19. Capuano P, Radanovic T, Wagner CA, et al., Intestinal and renal adaptation to a low-Pi diet of type II NaPi cotransporters in vitamin D receptor- and 1alphaOHase-deficient mice. Am J Physiol Cell Physiol. 2005; 288 (2): C429-434.
20. Segawa H, Kaneko I, Yamanaka S, et al., Intestinal Na-P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol. 2004; 287 (1): F39-47.
21. Xu H, Bai L, Collins JF, Ghishan FK,. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). Am J Physiol Cell Physiol. 2002; 282 (3): C487-93.
22. Beck L, et al., Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc Natl Acad Sci U S.A. 1998; 95 (9): 5372-7.
23. Myakala K, Motta S, Murer H, et al., Renal-specific and inducible depletion of NaPi-IIc/Slc34a3, the cotransporter mutated in HHRH, does not affect phosphate or calcium homeostasis in mice. Am J Physiol Renal Physiol. 2014 Apr 15; 306 (8): F833-43.
24. Segawa H, Onitsuka A, Kuwahata M, et al., Type IIc sodium-dependent phosphate transporter regulates calcium metabolism. J Am Soc Nephrol. 2009; 20 (1): 104-13.
25. Shibasaki Y, Etoh N, Hayasaka M, et al., Targeted deletion of the tybe IIb Na(+)-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality. Biochem Biophys Res Commun. 2009; 381 (4): 482-6.
26. Porret A, Merillat AM, Guichard S, Beermann F, Hummler E,. Tissue-specific transgenic and knockout mice. Methods Mol Biol. 2006; 337: 185-205.
27. Biber J, Stieger B, Stange G, Murer H,. Isolation of renal proximal tubular brush-border membranes. Nat Protoc. 2007; 2 (6): 1356-9.
28. Stoll R, Kinne R, Murer H,. Effect of dietary phosphate intake on phosphate transport by isolated rat renal brush-border vesicles. Biochem J. 1979; 180 (3): 465-70.
29. Custer M, Lotscher M, Biber J, Murer H, Kaissling B., Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry. Am J Physiol. 1994; 266 (5 Pt 2): F767-74.
30. Nowik M, Picard N, Stange G, et al., Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption. Pflugers Arch. 2008; 457 (2): 539-49.
31. Lotscher M, Kaissling B, Biber J, Murer H, Kempson SA, Levi M,. Regulation of rat renal Na/Pi-cotransporter by parathyroid hormone: immunohistochemistry. Kidney Int. 1996; 49 (4): 1010-11.
32. Villa-Bellosta R, Sorribas V., Role of rat sodium/phosphate cotransporters in the cell membrane transport of arsenate. Toxicol Appl Pharmacol. 2008; 232 (1): 125-34.
33. Khurana S, George SP., Regulation of cell structure and function by actin-binding proteins: villin's perspective. FEBS Lett. 2008; 582 (14): 2128-39.
34. Nishimura M, Naito S., Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet. 2008; 23 (1): 22-44.
35. Ma Y, Samaraweera M, Cooke-Hubley S, et al., Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization. Endocrinology. 2014; 155 (5): 1596-605.
36. Perwad F, Portale AA., Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23. Mol Cell Endocrinol. 2011; 347 (1-2): 17-24.
37. Deliot N, Hernando N, Horst-Liu Z, et al., Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i) cotransporter-Na+/H+ exchanger regulatory factor-1 complexes. Am J Physiol Cell Physiol. 2005; 289 (1): C159-67.
38. Gattineni J, Bates C, Twombley K, et al., FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1. Am J Physiol Renal Physiol. 2009; 297 (2): F282-91.
39. Segawa H, Kawakami E, Kaneko I, et al., Effect of hydrolysis-resistant FGF23-R179Q on dietary phosphate regulation of the renal type-II Na/Pi transporter. Pflugers Archiv. 2003; 446 (5): 585-92.
40. Weinman EJ, Steplock D, Shenolikar S, Biswas R., Fibroblast growth factor-23-mediated inhibition of renal phosphate transport in mice requires sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) and synergizes with parathyroid hormone. J Biol Chem. 2011; 286 (43): 37216-21.
41. Shimada T, Muto T, Urakawa I, et al., Mutant FGF-23 responsible for autosomal dominant hypophosphatemic, rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology. 2002; 143 (8): 3179-82.
42. Saito H, Kusano K, Kinosaki M, et al., Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem. 2003; 278 (4): 2206-11.
43. Hu MC, Shi M, Zhang J, et al., Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J. 2010; 24 (9): 3438-50.
44. Kato K, Jeanneau C, Tarp MA, et al., Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation. J Biol Chem. 2006; 281 (27): 18370-7.
45. White KE, Evans WE, O'Riordan JLH, et al., ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet. 2000; 26 (3): 345-8.
46. Strom TM, Jüppner H., PHEX, FGF23, DMP1 and beyond. Curr Opin Nephrol Hypertens. 2008; 17 (4): 357-62.
47. Kolek OI, Hines ER, Jones MD, et al., 1 alpha, 25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Am J Physiol Gastrointest Liver Physiol. 2005; 289 (6): G1036-42.
48. Saito H, Maeda A, Ohtomo S, et al., Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem. 2005; 280 (4): 2543-9.
49. Feng JQ, Clinkenbeard EL, Yuan B, White KE, Drezner MK., Osteocyte regulation of phosphate homeostasis and bone mineralization underlies the pathophysiology of the heritable disorders of rickets and osteomalacia. Bone. 2013; 54 (2): 213-21.
50. Yuan B, Feng JQ, Bowman S, et al., Hexa-D-arginine treatment increases 7B2∗PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype. J Bone Miner Res. 2013; 28 (1): 56-72.
51. Martin A, David V, Li H, Dai B, Feng JQ, Quarles LD,. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice. Mol Endocrinol. 2012; 26 (11): 1883-95.
52. Holm IA, Huang X, Kunkel LM., Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet. 1997; 60 (4): 790-7.
53. Lorenz-Depiereux B, Bastepe M, Benet-Pagès A, et al., DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis. Nat Genet. 2006; 38 (11): 1248-50.